Rbj
2021-07-21
Like and comment pls
HK-listed WuXi Biologics falls as shareholder plans $1.3 bln stake sale
免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。
分享至
微信
复制链接
精彩评论
我们需要你的真知灼见来填补这片空白
打开APP，发表看法
APP内打开
发表看法
3
7
{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":178420951,"tweetId":"178420951","gmtCreate":1626832773173,"gmtModify":1633770571734,"author":{"id":3575234837042918,"idStr":"3575234837042918","authorId":3575234837042918,"authorIdStr":"3575234837042918","name":"Rbj","avatar":"https://static.tigerbbs.com/363acddaa9c1e92690a16e7dd67b6484","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":4,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":25,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>Like and comment pls</p></body></html>","htmlText":"<html><head></head><body><p>Like and comment pls</p></body></html>","text":"Like and comment pls","highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":3,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/178420951","repostId":2153561380,"repostType":4,"repost":{"id":"2153561380","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1626832580,"share":"https://ttm.financial/m/news/2153561380?lang=&edition=full","pubTime":"2021-07-21 09:56","market":"hk","language":"en","title":"HK-listed WuXi Biologics falls as shareholder plans $1.3 bln stake sale","url":"https://stock-news.laohu8.com/highlight/detail?id=2153561380","media":"Reuters","summary":"** Shares of WuXi Biologics (Cayman) Inc fall 4.4% to HK$131.90, on course for their worst day since","content":"<p>** Shares of WuXi Biologics (Cayman) Inc fall 4.4% to HK$131.90, on course for their worst day since July 8, after a shareholder plans sale of HK$10.32 bln ($1.33 bln) shares at a discount</p>\n<p>** Stock biggest percentage decliner in the benchmark Hang Seng Index and the most actively traded by turnover</p>\n<p>** Shares sink to their lowest since July 13, and on course to fall for a third consecutive session</p>\n<p>** Jiangsu-based company says shareholder WuXi Biologics Holdings Ltd has entered into a block trade agreement with <a href=\"https://laohu8.com/S/MSTLW\">Morgan Stanley</a> & Co International Plc to sell 80 mln shares, or 1.89% stake, to independent third parties at HK$129 apiece</p>\n<p>** DEal reduces WuXi Biologics Holdings' stake in the company to 15.34% from about 17.22%</p>\n<p>** Both the Hong Kong Hang Seng Commerce & Industry Index and the healthcare index slip 0.2%</p>\n<p>** The Hang Seng China Enterprises Index climbs 0.5%, and the benchmark index gains 0.3%</p>\n<p>** As of last close, stock up 34.2% this year</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>HK-listed WuXi Biologics falls as shareholder plans $1.3 bln stake sale</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHK-listed WuXi Biologics falls as shareholder plans $1.3 bln stake sale\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-07-21 09:56</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>** Shares of WuXi Biologics (Cayman) Inc fall 4.4% to HK$131.90, on course for their worst day since July 8, after a shareholder plans sale of HK$10.32 bln ($1.33 bln) shares at a discount</p>\n<p>** Stock biggest percentage decliner in the benchmark Hang Seng Index and the most actively traded by turnover</p>\n<p>** Shares sink to their lowest since July 13, and on course to fall for a third consecutive session</p>\n<p>** Jiangsu-based company says shareholder WuXi Biologics Holdings Ltd has entered into a block trade agreement with <a href=\"https://laohu8.com/S/MSTLW\">Morgan Stanley</a> & Co International Plc to sell 80 mln shares, or 1.89% stake, to independent third parties at HK$129 apiece</p>\n<p>** DEal reduces WuXi Biologics Holdings' stake in the company to 15.34% from about 17.22%</p>\n<p>** Both the Hong Kong Hang Seng Commerce & Industry Index and the healthcare index slip 0.2%</p>\n<p>** The Hang Seng China Enterprises Index climbs 0.5%, and the benchmark index gains 0.3%</p>\n<p>** As of last close, stock up 34.2% this year</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"02269":"药明生物"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2153561380","content_text":"** Shares of WuXi Biologics (Cayman) Inc fall 4.4% to HK$131.90, on course for their worst day since July 8, after a shareholder plans sale of HK$10.32 bln ($1.33 bln) shares at a discount\n** Stock biggest percentage decliner in the benchmark Hang Seng Index and the most actively traded by turnover\n** Shares sink to their lowest since July 13, and on course to fall for a third consecutive session\n** Jiangsu-based company says shareholder WuXi Biologics Holdings Ltd has entered into a block trade agreement with Morgan Stanley & Co International Plc to sell 80 mln shares, or 1.89% stake, to independent third parties at HK$129 apiece\n** DEal reduces WuXi Biologics Holdings' stake in the company to 15.34% from about 17.22%\n** Both the Hong Kong Hang Seng Commerce & Industry Index and the healthcare index slip 0.2%\n** The Hang Seng China Enterprises Index climbs 0.5%, and the benchmark index gains 0.3%\n** As of last close, stock up 34.2% this year","news_type":1,"symbols_score_info":{"02269":0.9}},"isVote":1,"tweetType":1,"viewCount":444,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":17,"xxTargetLangEnum":"ORIG"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/178420951"}
精彩评论